H & H PHARMACEUTICALS
The computed 12-month bankruptcy probability of H & H PHARMACEUTICALS is 1.3% (low). The 2024 annual accounts show equity of €19.41M and a net result of €3.42M. Equity is growing by ~81.5% per year across the filed fiscal years. Its solvency ranks better than 59% of 596 sector peers (fiscal year 2023). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €19.41M |
| Net result | €3.42M |
| Better than sector | 59% |
| Active | 5 yrs |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 37.8% | 29.2% | |
| Net result | €13.90M | €35k | |
| Equity | €15.99M | €458k | |
| Gross operating margin | €219k | €104k | |
| Total assets | €42.26M | €1.84M |
Show 11 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | ander |
| Revenue | €1.74M |
| EBITDA | - |
| Net profit | €3.42M |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €41.66M |
| Equity | €19.41M |
| Debt | €22.25M |
| of which ≤ 1y | €3.57M |
| of which > 1y | €18.43M |
| Working capital | €4.68M |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 2.31 |
| Quick ratio | 2.31 |
| Working capital ratio | 11.2% |
| Solvency | 46.6% |
| Debt / equity | 1.15 |
| Long-term debt ratio | 0.95 |
| Interest coverage | - |
| Gross margin | - |
| Net margin | 197.2% |
| ROA | 8.2% |
| ROE | 17.6% |
| EBITDA margin | - |
| Days sales outstanding | 70d |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (23 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €41.66M |
| Fixed assets | 21/28 | €33.40M |
| Tangible fixed assets | 22/27 | €897k |
| Financial fixed assets | 28 | €32.51M |
| Current assets | 29/58 | €8.26M |
| Amounts receivable within one year | 40/41 | €4.75M |
| Cash & bank | 54/58 | €2.05M |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €41.66M |
| Equity | 10/15 | €19.41M |
| Contributions / capital | 10/11 | €10k |
| Reserves | 13 | €1.28M |
| Accumulated profits (losses) | 14 | €18.13M |
| Amounts payable | 17/49 | €22.25M |
| Amounts payable after one year | 17 | €18.43M |
| Amounts payable within one year | 42/48 | €3.57M |
| Trade debts payable within one year | 44 | €57 |
| Income statement | ||
| Turnover | 70 | €1.74M |
| Operating result | 9901 | €1.69M |
| Financial income | 75 | €4.91M |
| Financial charges | 65 | €3.18M |
| Result before taxes | 9903 | €3.42M |
| Net result for the period | 9904 | €3.42M |
| Result to be appropriated | 9905 | €3.42M |
-
Koen SmessaertDirectorState Gazette act 24124644 (22-08-2024)Current08-08-2024 → present
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Private limited company(610) |
| Incorporation | 14-12-2020 |
| Status | Active |
| Postal code | 1402 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25099D0012/00Y011 | Wallonia | 4,825 m² | 1 · 4,182 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
22-08-2024 Koen Smessaert appointed as director
- Koen Smessaert, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": "63.05.12-241.78",
"name": "Koen Smessaert",
"address": "Rue du petit champ, 7, 1450 Gentinnes",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2024-08-08",
"evidence_quote": "1.Nomination de Monsieur Koen Smessaert, domicili\u00E9 Rue du petit champ, 7, 1450 Gentinnes (NN 63.05.12-241.78) comme administrateur pour un mandat de 4 ans \u00E0 compter du 8 aout 2024.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "4"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "sole_shareholder_declaration",
"role": "enige_bestuurder",
"person": {
"rrn": null,
"name": "Laurent HAVERBEKE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Cette derni\u00E8re d\u00E9signe, comme pr\u00E9sident, Monsieur Laurent HAVERBEKE.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Laurent HAVERBEKE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Les titulaires de toutes les actions sont pr\u00E9sents ou repr\u00E9sent\u00E9s, l\u0027Assembl\u00E9e G\u00E9n\u00E9rale est d\u00E8s lors apte \u00E0 d\u00E9lib\u00E9rer.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-08-22",
"filing_date": "2024-08-09",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-08-09",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0759.775.660",
"name_full": "Voleca",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Laurent HAVERBEKE",
"org_rep_person_name": null,
"person_role_at_subject": "pr\u00E9sident"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}31-08-2023 Registered office moved
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "1402 Thines, avenue Thomas Edison 105 (Zoning Industriel Nivelles Sud-Zone 2)",
"city": null,
"region": null,
"street": "Thines",
"country": "BE",
"postcode": null,
"box_number": null,
"street_number": "1402",
"locality_suffix": "Zoning Industriel Nivelles Sud-Zone 2"
},
"old_address": null,
"effective_date": null,
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": null,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": 2,
"effective_date_qualifier": null,
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": null
}
],
"notary": {
"name": "Pablo De Doncker",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-08-31",
"filing_date": "2023-08-29",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"date": "2023-08-21",
"unanimous": null
},
"subject_company": {
"kbo": "0759.775.660",
"name_full": "H \u0026 H HOLDING",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"une exp\u00E9dition de l\u2019acte",
"statuts coordonn\u00E9s"
]
}| Legal nameFR | H & H PHARMACEUTICALS |